News and Trends 30 Jun 2016
Germany joins the Biotech Front against a ‘Silent Epidemic’ of the Liver
The German life sciences investor, Ellersbrook, is putting millions into Evotec‘s drug discovery program. Together the two join a biotech industry hunt for a therapy against a metabolic liver disease…